Cargando…

Herpes viruses and human papilloma virus in nasal polyposis and controls()

INTRODUCTION: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. OBJECTIVE: To compare the prevalence of hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioannidis, Dimitrios, Lachanas, Vasileios A., Florou, Zoe, Bizakis, John G., Petinaki, Efthymia, Skoulakis, Charalampos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442677/
https://www.ncbi.nlm.nih.gov/pubmed/26480900
http://dx.doi.org/10.1016/j.bjorl.2015.08.010
_version_ 1784782870817013760
author Ioannidis, Dimitrios
Lachanas, Vasileios A.
Florou, Zoe
Bizakis, John G.
Petinaki, Efthymia
Skoulakis, Charalampos E.
author_facet Ioannidis, Dimitrios
Lachanas, Vasileios A.
Florou, Zoe
Bizakis, John G.
Petinaki, Efthymia
Skoulakis, Charalampos E.
author_sort Ioannidis, Dimitrios
collection PubMed
description INTRODUCTION: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. OBJECTIVE: To compare the prevalence of human herpes viruses (1–6) and Human Papilloma Virus in adult patients with chronic rhinosinusitis with nasal polyps and healthy controls. METHODS: Viral DNA presence was evaluated by real-time polymerase chain reaction application to nasal polyps specimens from 91 chronic rhinosinusitis with nasal polyps patients and nasal turbinate mucosa from 38 healthy controls. RESULTS: Epstein–Barr virus positivity was higher in nasal polyps (24/91; 26.4%) versus controls (4/38; 10.5%), but the difference did not reach significance (p = 0.06). Human herpes virus-6 positivity was lower in nasal polyps (13/91; 14.29%) versus controls (10/38; 26.32%, p = 0.13). In chronic rhinosinusitis with nasal polyps group, 1 sample was herpes simplex virus-1-positive (1/91; 1.1%), and another was cytomegalovirus-positive (1/91; 1.1%), versus none in controls. No sample was positive for herpes simplex virus-2, varicella-zoster virus, high-risk-human papilloma viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and low-risk-human papilloma viruses (6, 11). CONCLUSION: Differences in Epstein–Barr virus and human herpes virus-6 positivity among patients with chronic rhinosinusitis with nasal polyps and healthy controls are not statistically significant, weakening the likelihood of their implication in chronic rhinosinusitis with nasal polyps pathogenesis.
format Online
Article
Text
id pubmed-9442677
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94426772022-09-09 Herpes viruses and human papilloma virus in nasal polyposis and controls() Ioannidis, Dimitrios Lachanas, Vasileios A. Florou, Zoe Bizakis, John G. Petinaki, Efthymia Skoulakis, Charalampos E. Braz J Otorhinolaryngol Original Article INTRODUCTION: Chronic rhinosinusitis with nasal polyps is a multifactorial disease entity with an unclear pathogenesis. Contradictory data exist in the literature on the potential implication of viral elements in adult patients with chronic rhinosinusitis. OBJECTIVE: To compare the prevalence of human herpes viruses (1–6) and Human Papilloma Virus in adult patients with chronic rhinosinusitis with nasal polyps and healthy controls. METHODS: Viral DNA presence was evaluated by real-time polymerase chain reaction application to nasal polyps specimens from 91 chronic rhinosinusitis with nasal polyps patients and nasal turbinate mucosa from 38 healthy controls. RESULTS: Epstein–Barr virus positivity was higher in nasal polyps (24/91; 26.4%) versus controls (4/38; 10.5%), but the difference did not reach significance (p = 0.06). Human herpes virus-6 positivity was lower in nasal polyps (13/91; 14.29%) versus controls (10/38; 26.32%, p = 0.13). In chronic rhinosinusitis with nasal polyps group, 1 sample was herpes simplex virus-1-positive (1/91; 1.1%), and another was cytomegalovirus-positive (1/91; 1.1%), versus none in controls. No sample was positive for herpes simplex virus-2, varicella-zoster virus, high-risk-human papilloma viruses (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and low-risk-human papilloma viruses (6, 11). CONCLUSION: Differences in Epstein–Barr virus and human herpes virus-6 positivity among patients with chronic rhinosinusitis with nasal polyps and healthy controls are not statistically significant, weakening the likelihood of their implication in chronic rhinosinusitis with nasal polyps pathogenesis. Elsevier 2015-09-08 /pmc/articles/PMC9442677/ /pubmed/26480900 http://dx.doi.org/10.1016/j.bjorl.2015.08.010 Text en © 2015 Associac¸ão Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Ioannidis, Dimitrios
Lachanas, Vasileios A.
Florou, Zoe
Bizakis, John G.
Petinaki, Efthymia
Skoulakis, Charalampos E.
Herpes viruses and human papilloma virus in nasal polyposis and controls()
title Herpes viruses and human papilloma virus in nasal polyposis and controls()
title_full Herpes viruses and human papilloma virus in nasal polyposis and controls()
title_fullStr Herpes viruses and human papilloma virus in nasal polyposis and controls()
title_full_unstemmed Herpes viruses and human papilloma virus in nasal polyposis and controls()
title_short Herpes viruses and human papilloma virus in nasal polyposis and controls()
title_sort herpes viruses and human papilloma virus in nasal polyposis and controls()
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442677/
https://www.ncbi.nlm.nih.gov/pubmed/26480900
http://dx.doi.org/10.1016/j.bjorl.2015.08.010
work_keys_str_mv AT ioannidisdimitrios herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols
AT lachanasvasileiosa herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols
AT florouzoe herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols
AT bizakisjohng herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols
AT petinakiefthymia herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols
AT skoulakischaralampose herpesvirusesandhumanpapillomavirusinnasalpolyposisandcontrols